Regenerative medicine in Japan is governed by legislation that separates approved cell products from treatments provided privately under a registration system. Clinics offering the latter must submit their plan to a certified committee before providing it. Knowing this distinction helps interpret what a clinic is actually offering you.
Registration is not the same as proof of effectiveness for your condition. It confirms that a plan has been reviewed for safety and process, not that outcomes are established. Asking a clinic to explain this difference is a fair question, and providers used to international patients generally answer it without difficulty.
For patients traveling from abroad, this framework mainly affects what can be offered and how it is documented. Ask which category your proposed treatment falls under, what documentation you will receive, and whether records can be shared with your physician at home. Those answers matter more for planning than the regulatory detail itself. Ask in particular whether the documentation you receive will be in English, since records that cannot be read by your own physician are of limited practical use.
